Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice.To evaluate the incidences of treatment-related adverse events of PD-1 and PD-L1 inhibitors and the differences between different drugs and cancer types.PubMed, Web of Science, Embase, and Scopus were searched from...